Skip to content

Pathogenesis of congenital deformation of sternocleidomastoid muscle

Pathogenesis of congenital deformation of sternocleidomastoid muscle

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047711
Enrollment
Unknown
Registered
2021-06-23
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital torticollis

Interventions

case series:No

Sponsors

The Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A clear diagnosis of patients with congenital muscular torticollis and their families; 2. Patients and their families who have voluntarily signed the genetic testing and consultation "Informed Consent".

Exclusion criteria

Exclusion criteria: 1. The sample is mixed with other individual cells or tissues (sample contamination); 2. The subject has received allogeneic blood transfusion, organ transplantation, stem cell therapy, etc. recently (within six months); 3. True and accurate relative information not provided by the subject or his guardian; 4. The genetic etiology has been determined.

Design outcomes

Primary

MeasureTime frame
Detection of pathogenic site;

Secondary

MeasureTime frame
Sex;Age;Side;Age of Sugery;Fetal Position;Family History;Head and Neck Rotation Angle;Lateral Flexion Angle;

Countries

China

Contacts

Public ContactLi Wenchao

The Faculty of Pediatrics, the Seventh Medical Center of PLA General Hospital

liwenchao301@301.com+86 15801302889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026